Abivax S.A. - Ordinary Shares, nominal value Euro 0.01 per share (ABVX)
CUSIP: 00370M103
Q3 2024 13F Holders as of 30 Sep 2024
- Type / Class
- Equity / Ordinary Shares, nominal value Euro 0.01 per share
- Shares outstanding
- 78,459,900
- Total 13F shares
- 27,383,884
- Share change
- -720,926
- Total reported value
- $312,847,988
- Price per share
- $11.52
- Number of holders
- 40
- Value change
- -$8,252,199
- Number of buys
- 20
- Number of sells
- 13
Quarterly Holders Quick Answers
What is CUSIP 00370M103?
CUSIP 00370M103 identifies ABVX - Abivax S.A. - Ordinary Shares, nominal value Euro 0.01 per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 00370M103:
Top shareholders of ABVX - Abivax S.A. - Ordinary Shares, nominal value Euro 0.01 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| TCG Crossover Management, LLC |
13F
|
Company |
7.7%
|
6,056,596
|
$80,068,199 | — | 30 Jun 2024 | |
| Deep Track Capital, LP |
13F
|
Company |
5.3%
|
4,179,763
|
$55,256,467 | — | 30 Jun 2024 | |
| GREAT POINT PARTNERS LLC |
13F
|
Company |
3.2%
|
2,472,188
|
$32,682,325 | — | 30 Jun 2024 | |
| Cormorant Asset Management, LP |
13F
|
Company |
2.7%
|
2,130,000
|
$28,158,600 | — | 30 Jun 2024 | |
| Blackstone Inc. |
13F
|
Company |
2.4%
|
1,862,037
|
$24,616,129 | — | 30 Jun 2024 | |
| FRANKLIN RESOURCES INC |
13F
|
Company |
1.8%
|
1,395,052
|
$18,442,587 | — | 30 Jun 2024 | |
| VR Adviser, LLC |
13F
|
Company |
1.7%
|
1,345,780
|
$17,791,212 | — | 30 Jun 2024 | |
| Commodore Capital LP |
13F
|
Company |
1.6%
|
1,284,110
|
$16,975,934 | — | 30 Jun 2024 | |
| JANUS HENDERSON GROUP PLC |
13F
|
Company |
1.5%
|
1,175,514
|
$15,716,622 | — | 30 Jun 2024 | |
| Nantahala Capital Management, LLC |
13F
|
Company |
1.3%
|
985,634
|
$13,030,081 | — | 30 Jun 2024 | |
| Samsara BioCapital, LLC |
13F
|
Company |
1.1%
|
850,000
|
$11,237,000 | — | 30 Jun 2024 | |
| Saturn V Capital Management LP |
13F
|
Company |
0.8%
|
627,760
|
$8,298,987 | — | 30 Jun 2024 | |
| MORGAN STANLEY |
13F
|
Company |
0.72%
|
563,553
|
$7,450,170 | — | 30 Jun 2024 | |
| ADAGE CAPITAL PARTNERS GP, L.L.C. |
13F
|
Company |
0.67%
|
525,000
|
$6,940,500 | — | 30 Jun 2024 | |
| SILVERARC CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.58%
|
455,800
|
$6,025,676 | — | 30 Jun 2024 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.58%
|
454,760
|
$6,011,927 | — | 30 Jun 2024 | |
| Point72 Asset Management, L.P. |
13F
|
Company |
0.54%
|
423,600
|
$5,599,992 | — | 30 Jun 2024 | |
| Rosalind Advisors, Inc. |
13F
|
Company |
0.48%
|
378,416
|
$5,002,659 | — | 30 Jun 2024 | |
| Walleye Capital LLC |
13F
|
Company |
0.23%
|
176,610
|
$2,334,784 | — | 30 Jun 2024 | |
| Atika Capital Management LLC |
13F
|
Company |
0.22%
|
170,637
|
$2,255,821 | — | 30 Jun 2024 | |
| KENNEDY CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.17%
|
132,031
|
$1,745,450 | — | 30 Jun 2024 | |
| Aberdeen Group plc |
13F
|
Company |
0.15%
|
118,206
|
$1,562,683 | — | 30 Jun 2024 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.1%
|
77,602
|
$1,025,898 | — | 30 Jun 2024 | |
| Polar Asset Management Partners Inc. |
13F
|
Company |
0.07%
|
53,239
|
$703,820 | — | 30 Jun 2024 | |
| HighVista Strategies LLC |
13F
|
Company |
0.06%
|
49,509
|
$654,509 | — | 30 Jun 2024 | |
| BANTAMAC CAPITAL, LLC |
13F
|
Company |
0.04%
|
34,750
|
$459,395 | — | 30 Jun 2024 | |
| Woodline Partners LP |
13F
|
Company |
0.04%
|
31,284
|
$413,574 | — | 30 Jun 2024 | |
| ADAR1 Capital Management, LLC |
13F
|
Company |
0.03%
|
27,000
|
$356,940 | — | 30 Jun 2024 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.02%
|
14,389
|
$190,222 | — | 30 Jun 2024 | |
| CAXTON CORP |
13F
|
Company |
0.02%
|
13,900
|
$183,760 | — | 30 Jun 2024 | |
| HighTower Advisors, LLC |
13F
|
Company |
0.01%
|
10,000
|
$132,000 | — | 30 Jun 2024 | |
| Sandia Investment Management LP |
13F
|
Company |
0.01%
|
7,500
|
$99,150 | — | 30 Jun 2024 | |
| BNP PARIBAS FINANCIAL MARKETS |
13F
|
Company |
0.01%
|
7,144
|
$94,444 | — | 30 Jun 2024 | |
| Cubist Systematic Strategies, LLC |
13F
|
Company |
0.01%
|
6,027
|
$79,677 | — | 30 Jun 2024 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0%
|
2,819
|
$37,267 | — | 30 Jun 2024 | |
| RHUMBLINE ADVISERS |
13F
|
Company |
0%
|
594
|
$7,851 | — | 30 Jun 2024 | |
| Financial Management Professionals, Inc. |
13F
|
Company |
0%
|
100
|
$1,000 | — | 30 Jun 2024 | |
| OSAIC HOLDINGS, INC. |
13F
|
Company |
0%
|
6
|
$79 | — | 30 Jun 2024 |
Institutional Holders of Abivax S.A. - Ordinary Shares, nominal value Euro 0.01 per share (ABVX) as of Q3 2024
As of 30 Sep 2024,
Abivax S.A. - Ordinary Shares, nominal value Euro 0.01 per share (ABVX) was held by
40 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
27,383,884 shares.
The largest 10 holders included
TCG Crossover Management, LLC, Deep Track Capital, LP, Cormorant Asset Management, LP, GREAT POINT PARTNERS LLC, Blackstone Inc., VR Adviser, LLC, FRANKLIN RESOURCES INC, COMMODORE CAPITAL LP, Nantahala Capital Management, LLC, and Samsara BioCapital, LLC.
This page lists
40
institutional shareholders reporting positions in this security
for the Q3 2024 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q3 2024 vs Q2 2024 Across Filers
Q2 2024 holders
38
Q3 2024 holders
40
Holder diff
2
| Investor | Q2 2024 Shares | Q3 2024 Shares | Share Diff | Share Chg % | Q2 2024 Value $ | Q3 2024 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.